Global Medicine Market Size, Status and Forecast 2020-2026

May 2020 | 128 pages | ID: G9600F27FEA8EN
QYResearch

Abstracts

This report focuses on the global Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Pfizer
• Roche
• Sanofi
• Johnson & Johnson
• Merck & Co. (MSD)
• Novartis
• AbbVie
• Gilead Sciences
• GlaxoSmithKline (GSK)
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Eli Lilly
• Teva
• Bayer
• Novo Nordisk
• Allergan
• Takeda
• Boehringer Ingelheim
• Takeda

Market segment by Type, the product can be split into

• Brand Drugs
• Generic Drug

Market segment by Application, split into

• Hospital
• Clinic
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Medicine status, future forecast, growth opportunity, key market and key players.
• To present the Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Medicine are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Medicine Revenue
1.4 Market Analysis by Type
  1.4.1 Global Medicine Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Brand Drugs
  1.4.3 Generic Drug
1.5 Market by Application
  1.5.1 Global Medicine Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Medicine Market Perspective (2015-2026)
2.2 Medicine Growth Trends by Regions
  2.2.1 Medicine Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Medicine Historic Market Share by Regions (2015-2020)
  2.2.3 Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Medicine Market Growth Strategy
  2.3.6 Primary Interviews with Key Medicine Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Medicine Players by Market Size
  3.1.1 Global Top Medicine Players by Revenue (2015-2020)
  3.1.2 Global Medicine Revenue Market Share by Players (2015-2020)
  3.1.3 Global Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Medicine Market Concentration Ratio
  3.2.1 Global Medicine Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Medicine Revenue in 2019
3.3 Medicine Key Players Head office and Area Served
3.4 Key Players Medicine Product Solution and Service
3.5 Date of Enter into Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Medicine Historic Market Size by Type (2015-2020)
4.2 Global Medicine Forecasted Market Size by Type (2021-2026)

5 MEDICINE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Medicine Market Size by Application (2015-2020)
5.2 Global Medicine Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Medicine Market Size (2015-2020)
6.2 Medicine Key Players in North America (2019-2020)
6.3 North America Medicine Market Size by Type (2015-2020)
6.4 North America Medicine Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Medicine Market Size (2015-2020)
7.2 Medicine Key Players in Europe (2019-2020)
7.3 Europe Medicine Market Size by Type (2015-2020)
7.4 Europe Medicine Market Size by Application (2015-2020)

8 CHINA

8.1 China Medicine Market Size (2015-2020)
8.2 Medicine Key Players in China (2019-2020)
8.3 China Medicine Market Size by Type (2015-2020)
8.4 China Medicine Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Medicine Market Size (2015-2020)
9.2 Medicine Key Players in Japan (2019-2020)
9.3 Japan Medicine Market Size by Type (2015-2020)
9.4 Japan Medicine Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Medicine Market Size (2015-2020)
10.2 Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Medicine Market Size by Application (2015-2020)

11 INDIA

11.1 India Medicine Market Size (2015-2020)
11.2 Medicine Key Players in India (2019-2020)
11.3 India Medicine Market Size by Type (2015-2020)
11.4 India Medicine Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Medicine Market Size (2015-2020)
12.2 Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Medicine Market Size by Type (2015-2020)
12.4 Central & South America Medicine Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Medicine Introduction
  13.1.4 Pfizer Revenue in Medicine Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Medicine Introduction
  13.2.4 Roche Revenue in Medicine Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Sanofi
  13.3.1 Sanofi Company Details
  13.3.2 Sanofi Business Overview and Its Total Revenue
  13.3.3 Sanofi Medicine Introduction
  13.3.4 Sanofi Revenue in Medicine Business (2015-2020)
  13.3.5 Sanofi Recent Development
13.4 Johnson & Johnson
  13.4.1 Johnson & Johnson Company Details
  13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.4.3 Johnson & Johnson Medicine Introduction
  13.4.4 Johnson & Johnson Revenue in Medicine Business (2015-2020)
  13.4.5 Johnson & Johnson Recent Development
13.5 Merck & Co. (MSD)
  13.5.1 Merck & Co. (MSD) Company Details
  13.5.2 Merck & Co. (MSD) Business Overview and Its Total Revenue
  13.5.3 Merck & Co. (MSD) Medicine Introduction
  13.5.4 Merck & Co. (MSD) Revenue in Medicine Business (2015-2020)
  13.5.5 Merck & Co. (MSD) Recent Development
13.6 Novartis
  13.6.1 Novartis Company Details
  13.6.2 Novartis Business Overview and Its Total Revenue
  13.6.3 Novartis Medicine Introduction
  13.6.4 Novartis Revenue in Medicine Business (2015-2020)
  13.6.5 Novartis Recent Development
13.7 AbbVie
  13.7.1 AbbVie Company Details
  13.7.2 AbbVie Business Overview and Its Total Revenue
  13.7.3 AbbVie Medicine Introduction
  13.7.4 AbbVie Revenue in Medicine Business (2015-2020)
  13.7.5 AbbVie Recent Development
13.8 Gilead Sciences
  13.8.1 Gilead Sciences Company Details
  13.8.2 Gilead Sciences Business Overview and Its Total Revenue
  13.8.3 Gilead Sciences Medicine Introduction
  13.8.4 Gilead Sciences Revenue in Medicine Business (2015-2020)
  13.8.5 Gilead Sciences Recent Development
13.9 GlaxoSmithKline (GSK)
  13.9.1 GlaxoSmithKline (GSK) Company Details
  13.9.2 GlaxoSmithKline (GSK) Business Overview and Its Total Revenue
  13.9.3 GlaxoSmithKline (GSK) Medicine Introduction
  13.9.4 GlaxoSmithKline (GSK) Revenue in Medicine Business (2015-2020)
  13.9.5 GlaxoSmithKline (GSK) Recent Development
13.10 Amgen
  13.10.1 Amgen Company Details
  13.10.2 Amgen Business Overview and Its Total Revenue
  13.10.3 Amgen Medicine Introduction
  13.10.4 Amgen Revenue in Medicine Business (2015-2020)
  13.10.5 Amgen Recent Development
13.11 AstraZeneca
  10.11.1 AstraZeneca Company Details
  10.11.2 AstraZeneca Business Overview and Its Total Revenue
  10.11.3 AstraZeneca Medicine Introduction
  10.11.4 AstraZeneca Revenue in Medicine Business (2015-2020)
  10.11.5 AstraZeneca Recent Development
13.12 Bristol-Myers Squibb
  10.12.1 Bristol-Myers Squibb Company Details
  10.12.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  10.12.3 Bristol-Myers Squibb Medicine Introduction
  10.12.4 Bristol-Myers Squibb Revenue in Medicine Business (2015-2020)
  10.12.5 Bristol-Myers Squibb Recent Development
13.13 Eli Lilly
  10.13.1 Eli Lilly Company Details
  10.13.2 Eli Lilly Business Overview and Its Total Revenue
  10.13.3 Eli Lilly Medicine Introduction
  10.13.4 Eli Lilly Revenue in Medicine Business (2015-2020)
  10.13.5 Eli Lilly Recent Development
13.14 Teva
  10.14.1 Teva Company Details
  10.14.2 Teva Business Overview and Its Total Revenue
  10.14.3 Teva Medicine Introduction
  10.14.4 Teva Revenue in Medicine Business (2015-2020)
  10.14.5 Teva Recent Development
13.15 Bayer
  10.15.1 Bayer Company Details
  10.15.2 Bayer Business Overview and Its Total Revenue
  10.15.3 Bayer Medicine Introduction
  10.15.4 Bayer Revenue in Medicine Business (2015-2020)
  10.15.5 Bayer Recent Development
13.16 Novo Nordisk
  10.16.1 Novo Nordisk Company Details
  10.16.2 Novo Nordisk Business Overview and Its Total Revenue
  10.16.3 Novo Nordisk Medicine Introduction
  10.16.4 Novo Nordisk Revenue in Medicine Business (2015-2020)
  10.16.5 Novo Nordisk Recent Development
13.17 Allergan
  10.17.1 Allergan Company Details
  10.17.2 Allergan Business Overview and Its Total Revenue
  10.17.3 Allergan Medicine Introduction
  10.17.4 Allergan Revenue in Medicine Business (2015-2020)
  10.17.5 Allergan Recent Development
13.18 Takeda
  10.18.1 Takeda Company Details
  10.18.2 Takeda Business Overview and Its Total Revenue
  10.18.3 Takeda Medicine Introduction
  10.18.4 Takeda Revenue in Medicine Business (2015-2020)
  10.18.5 Takeda Recent Development
13.19 Boehringer Ingelheim
  10.19.1 Boehringer Ingelheim Company Details
  10.19.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  10.19.3 Boehringer Ingelheim Medicine Introduction
  10.19.4 Boehringer Ingelheim Revenue in Medicine Business (2015-2020)
  10.19.5 Boehringer Ingelheim Recent Development
13.20 Takeda
  10.20.1 Takeda Company Details
  10.20.2 Takeda Business Overview and Its Total Revenue
  10.20.3 Takeda Medicine Introduction
  10.20.4 Takeda Revenue in Medicine Business (2015-2020)
  10.20.5 Takeda Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Medicine Revenue
Table 3. Ranking of Global Top Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Brand Drugs
Table 6. Key Players of Generic Drug
Table 7. Global Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Medicine Market Share by Regions (2015-2020)
Table 11. Global Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Medicine Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Medicine Market Growth Strategy
Table 17. Main Points Interviewed from Key Medicine Players
Table 18. Global Medicine Revenue by Players (2015-2020) (Million US$)
Table 19. Global Medicine Market Share by Players (2015-2020)
Table 20. Global Top Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medicine as of 2019)
Table 21. Global Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Medicine Product Solution and Service
Table 24. Date of Enter into Medicine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Medicine Market Size by Type (2015-2020) (Million US$)
Table 27. Global Medicine Market Size Share by Type (2015-2020)
Table 28. Global Medicine Revenue Market Share by Type (2021-2026)
Table 29. Global Medicine Market Size Share by Application (2015-2020)
Table 30. Global Medicine Market Size by Application (2015-2020) (Million US$)
Table 31. Global Medicine Market Size Share by Application (2021-2026)
Table 32. North America Key Players Medicine Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Medicine Market Share (2019-2020)
Table 34. North America Medicine Market Size by Type (2015-2020) (Million US$)
Table 35. North America Medicine Market Share by Type (2015-2020)
Table 36. North America Medicine Market Size by Application (2015-2020) (Million US$)
Table 37. North America Medicine Market Share by Application (2015-2020)
Table 38. Europe Key Players Medicine Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Medicine Market Share (2019-2020)
Table 40. Europe Medicine Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Medicine Market Share by Type (2015-2020)
Table 42. Europe Medicine Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Medicine Market Share by Application (2015-2020)
Table 44. China Key Players Medicine Revenue (2019-2020) (Million US$)
Table 45. China Key Players Medicine Market Share (2019-2020)
Table 46. China Medicine Market Size by Type (2015-2020) (Million US$)
Table 47. China Medicine Market Share by Type (2015-2020)
Table 48. China Medicine Market Size by Application (2015-2020) (Million US$)
Table 49. China Medicine Market Share by Application (2015-2020)
Table 50. Japan Key Players Medicine Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Medicine Market Share (2019-2020)
Table 52. Japan Medicine Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Medicine Market Share by Type (2015-2020)
Table 54. Japan Medicine Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Medicine Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Medicine Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Medicine Market Share (2019-2020)
Table 58. Southeast Asia Medicine Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Medicine Market Share by Type (2015-2020)
Table 60. Southeast Asia Medicine Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Medicine Market Share by Application (2015-2020)
Table 62. India Key Players Medicine Revenue (2019-2020) (Million US$)
Table 63. India Key Players Medicine Market Share (2019-2020)
Table 64. India Medicine Market Size by Type (2015-2020) (Million US$)
Table 65. India Medicine Market Share by Type (2015-2020)
Table 66. India Medicine Market Size by Application (2015-2020) (Million US$)
Table 67. India Medicine Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Medicine Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Medicine Market Share (2019-2020)
Table 70. Central & South America Medicine Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Medicine Market Share by Type (2015-2020)
Table 72. Central & South America Medicine Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Medicine Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Medicine Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Product
Table 82. Roche Revenue in Medicine Business (2015-2020) (Million US$)
Table 83. Roche Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Product
Table 87. Sanofi Revenue in Medicine Business (2015-2020) (Million US$)
Table 88. Sanofi Recent Development
Table 89. Johnson & Johnson Company Details
Table 90. Johnson & Johnson Business Overview
Table 91. Johnson & Johnson Product
Table 92. Johnson & Johnson Revenue in Medicine Business (2015-2020) (Million US$)
Table 93. Johnson & Johnson Recent Development
Table 94. Merck & Co. (MSD) Company Details
Table 95. Merck & Co. (MSD) Business Overview
Table 96. Merck & Co. (MSD) Product
Table 97. Merck & Co. (MSD) Revenue in Medicine Business (2015-2020) (Million US$)
Table 98. Merck & Co. (MSD) Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Product
Table 102. Novartis Revenue in Medicine Business (2015-2020) (Million US$)
Table 103. Novartis Recent Development
Table 104. AbbVie Company Details
Table 105. AbbVie Business Overview
Table 106. AbbVie Product
Table 107. AbbVie Revenue in Medicine Business (2015-2020) (Million US$)
Table 108. AbbVie Recent Development
Table 109. Gilead Sciences Business Overview
Table 110. Gilead Sciences Product
Table 111. Gilead Sciences Company Details
Table 112. Gilead Sciences Revenue in Medicine Business (2015-2020) (Million US$)
Table 113. Gilead Sciences Recent Development
Table 114. GlaxoSmithKline (GSK) Company Details
Table 115. GlaxoSmithKline (GSK) Business Overview
Table 116. GlaxoSmithKline (GSK) Product
Table 117. GlaxoSmithKline (GSK) Revenue in Medicine Business (2015-2020) (Million US$)
Table 118. GlaxoSmithKline (GSK) Recent Development
Table 119. Amgen Company Details
Table 120. Amgen Business Overview
Table 121. Amgen Product
Table 122. Amgen Revenue in Medicine Business (2015-2020) (Million US$)
Table 123. Amgen Recent Development
Table 124. AstraZeneca Company Details
Table 125. AstraZeneca Business Overview
Table 126. AstraZeneca Product
Table 127. AstraZeneca Revenue in Medicine Business (2015-2020) (Million US$)
Table 128. AstraZeneca Recent Development
Table 129. Bristol-Myers Squibb Company Details
Table 130. Bristol-Myers Squibb Business Overview
Table 131. Bristol-Myers Squibb Product
Table 132. Bristol-Myers Squibb Revenue in Medicine Business (2015-2020) (Million US$)
Table 133. Bristol-Myers Squibb Recent Development
Table 134. Eli Lilly Company Details
Table 135. Eli Lilly Business Overview
Table 136. Eli Lilly Product
Table 137. Eli Lilly Revenue in Medicine Business (2015-2020) (Million US$)
Table 138. Eli Lilly Recent Development
Table 139. Teva Company Details
Table 140. Teva Business Overview
Table 141. Teva Product
Table 142. Teva Revenue in Medicine Business (2015-2020) (Million US$)
Table 143. Teva Recent Development
Table 144. Bayer Company Details
Table 145. Bayer Business Overview
Table 146. Bayer Product
Table 147. Bayer Revenue in Medicine Business (2015-2020) (Million US$)
Table 148. Bayer Recent Development
Table 149. Novo Nordisk Company Details
Table 150. Novo Nordisk Business Overview
Table 151. Novo Nordisk Product
Table 152. Novo Nordisk Revenue in Medicine Business (2015-2020) (Million US$)
Table 153. Novo Nordisk Recent Development
Table 154. Allergan Company Details
Table 155. Allergan Business Overview
Table 156. Allergan Product
Table 157. Allergan Revenue in Medicine Business (2015-2020) (Million US$)
Table 158. Allergan Recent Development
Table 159. Takeda Company Details
Table 160. Takeda Business Overview
Table 161. Takeda Product
Table 162. Takeda Revenue in Medicine Business (2015-2020) (Million US$)
Table 163. Takeda Recent Development
Table 164. Boehringer Ingelheim Company Details
Table 165. Boehringer Ingelheim Business Overview
Table 166. Boehringer Ingelheim Product
Table 167. Boehringer Ingelheim Revenue in Medicine Business (2015-2020) (Million US$)
Table 168. Boehringer Ingelheim Recent Development
Table 169. Takeda Company Details
Table 170. Takeda Business Overview
Table 171. Takeda Product
Table 172. Takeda Revenue in Medicine Business (2015-2020) (Million US$)
Table 173. Takeda Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Medicine Market Share by Type: 2020 VS 2026
Figure 2. Brand Drugs Features
Figure 3. Generic Drug Features
Figure 4. Global Medicine Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Medicine Report Years Considered
Figure 9. Global Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Medicine Market Share by Regions: 2020 VS 2026
Figure 11. Global Medicine Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Medicine Market Share by Players in 2019
Figure 14. Global Top Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medicine as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Medicine Revenue in 2019
Figure 16. North America Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Pfizer Revenue Growth Rate in Medicine Business (2015-2020)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Medicine Business (2015-2020)
Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi Revenue Growth Rate in Medicine Business (2015-2020)
Figure 29. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Johnson & Johnson Revenue Growth Rate in Medicine Business (2015-2020)
Figure 31. Merck & Co. (MSD) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Merck & Co. (MSD) Revenue Growth Rate in Medicine Business (2015-2020)
Figure 33. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Novartis Revenue Growth Rate in Medicine Business (2015-2020)
Figure 35. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AbbVie Revenue Growth Rate in Medicine Business (2015-2020)
Figure 37. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Gilead Sciences Revenue Growth Rate in Medicine Business (2015-2020)
Figure 39. GlaxoSmithKline (GSK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. GlaxoSmithKline (GSK) Revenue Growth Rate in Medicine Business (2015-2020)
Figure 41. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Amgen Revenue Growth Rate in Medicine Business (2015-2020)
Figure 43. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. AstraZeneca Revenue Growth Rate in Medicine Business (2015-2020)
Figure 45. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Medicine Business (2015-2020)
Figure 47. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Eli Lilly Revenue Growth Rate in Medicine Business (2015-2020)
Figure 49. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Teva Revenue Growth Rate in Medicine Business (2015-2020)
Figure 51. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bayer Revenue Growth Rate in Medicine Business (2015-2020)
Figure 53. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novo Nordisk Revenue Growth Rate in Medicine Business (2015-2020)
Figure 55. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Allergan Revenue Growth Rate in Medicine Business (2015-2020)
Figure 57. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Takeda Revenue Growth Rate in Medicine Business (2015-2020)
Figure 59. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Medicine Business (2015-2020)
Figure 61. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Takeda Revenue Growth Rate in Medicine Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed